Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Bugat

Showing results (81-90 of 149) with videos related to

Pageof 15
Sort By:
Acta Medica Austriaca|January 1, 1989
Clinical and pharmacokinetic study of intraperitoneal cisplatin at two dose levels: 100 mg/m2 alone or 200 mg/m2 with i.v. sodium thiosulfateP Canal, M de Forni, E Chatelut, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Pharmacokinetics and toxicity of two modalities of etoposide infusion in metastatic non-small-cell lung carcinomaE Chatelut, C Chevreau, E Blancy, et al.
Bulletin Du Cancer|September 1, 1996
[A phase II study with mitoxantrone-vinorelbine association in the treatment of advanced breast cancer in elderly women]L Gladieff, P Houyau, J Mihura, et al.
Annales De Radiologie|January 1, 1987
[Hepatic arterial lipiodolization and x-ray computed tomography diagnosis of malignant liver tumors. Experience apropos of 33 cases]J L Puech, H Rousseau, D Portalez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 25, 2003
Phase I and pharmacological study of an oxaliplatin and carboplatin combination in advanced malignanciesC Mita, E Chatelut, M Bekradda, et al.
Bulletin Du Cancer|August 1, 1995
[Relations between hematological toxicity and total and free plasma levels of etoposide in daily oral administration]M Lavit, C Chevreau, E Chatelut, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Phase I/II pharmacokinetic study of mitoxantrone by continuous venous infusion in patients with solid tumours and lymphoproliferative diseasesM de Forni, S Lachau, F Huguet, et al.
World Journal of Surgery|January 1, 1992
Pre-operative radiotherapy as adjuvant treatment in rectal cancerF Izar, G Fourtanier, B Pradere, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 28, 2001
Carcinocythemia as the single extension of breast cancer: report of a case and review of the literatureS Seronie-Vivien, E Mery, J P Delord, et al.
International Journal of Cancer|March 1, 1994
Response of four human ovarian carcinoma cell lines to all-trans retinoic acid: relationship with induction of differentiation and retinoic acid receptor expressionM J Caliaro, C Marmouget, S Guichard, et al.
Pageof 15

Showing results (81-90 of 149) with videos related to

Sort By:
Pageof 15
Acta Medica Austriaca|January 1, 1989
Clinical and pharmacokinetic study of intraperitoneal cisplatin at two dose levels: 100 mg/m2 alone or 200 mg/m2 with i.v. sodium thiosulfateP Canal, M de Forni, E Chatelut, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Pharmacokinetics and toxicity of two modalities of etoposide infusion in metastatic non-small-cell lung carcinomaE Chatelut, C Chevreau, E Blancy, et al.
Bulletin Du Cancer|September 1, 1996
[A phase II study with mitoxantrone-vinorelbine association in the treatment of advanced breast cancer in elderly women]L Gladieff, P Houyau, J Mihura, et al.
Annales De Radiologie|January 1, 1987
[Hepatic arterial lipiodolization and x-ray computed tomography diagnosis of malignant liver tumors. Experience apropos of 33 cases]J L Puech, H Rousseau, D Portalez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 25, 2003
Phase I and pharmacological study of an oxaliplatin and carboplatin combination in advanced malignanciesC Mita, E Chatelut, M Bekradda, et al.
Bulletin Du Cancer|August 1, 1995
[Relations between hematological toxicity and total and free plasma levels of etoposide in daily oral administration]M Lavit, C Chevreau, E Chatelut, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Phase I/II pharmacokinetic study of mitoxantrone by continuous venous infusion in patients with solid tumours and lymphoproliferative diseasesM de Forni, S Lachau, F Huguet, et al.
World Journal of Surgery|January 1, 1992
Pre-operative radiotherapy as adjuvant treatment in rectal cancerF Izar, G Fourtanier, B Pradere, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 28, 2001
Carcinocythemia as the single extension of breast cancer: report of a case and review of the literatureS Seronie-Vivien, E Mery, J P Delord, et al.
International Journal of Cancer|March 1, 1994
Response of four human ovarian carcinoma cell lines to all-trans retinoic acid: relationship with induction of differentiation and retinoic acid receptor expressionM J Caliaro, C Marmouget, S Guichard, et al.
Pageof 15